Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
Evaluation of the Safety, Pharmacokinetics, and Preliminary Effect on Scar Formation by RXI-109 (NCT01640912)RXi Pharmaceuticals, Corp.2012-06-01
S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer (NCT01693445)Hallym University Medical Center2012-06-01
The Effects of the Direct Acting Antiviral Agent Boceprevir on the Pharmacokinetics of Maraviroc in Healthy Volunteers (NCT01627717)Centre hospitalier de l'Université de Montréal (CHUM)2012-06-01
Biomarkers for the Early Diagnosis, Prediction, Prognosis for Colorectal Cancers (NCT01828918)Kaohsiung Medical University Chung-Ho Memorial Hospital2012-06-01
Bone Marrow vs Liver as Site for Islet Transplantation (NCT01722682)Ospedale San Raffaele2012-06-01
Physical Therapy in Pregnant Women With Preeclampsia (NCT01630772)University of Sao Paulo2012-06-01
The Effects of Summer Employment on Disadvantaged Youth: Experimental Evidence (NCT01947452)University of Chicago2012-06-01
Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors (NCT01629758)Bristol-Myers Squibb2012-06-01
Allogenic Transplantation of Ex-vivo Expanded Cord Blood (CB) (NCT01235468)Dr. Avichai Shimoni MD2012-06-01
Safety and Pharmacokinetis of TAP311 in Dyslipidemic Patients (NCT01632358)Novartis Pharmaceuticals2012-06-01
Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinoma (NCT01618253)Medical College of Wisconsin2012-06-01
Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects (NCT01646489)Santaris Pharma A/S2012-06-01
Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole (NCT01660477)Astellas Pharma Global Development, Inc.2012-06-01
Compare the Effect of a Remote Monitoring System Using the EXACT Tool to Reduce Hospitalizations Due to Chronic Obstructive Pulmonary Disease (COPD) Exacerbations. EXACT = Exacerbations of Chronic Pulmonary Disease Tool. (NCT01744028)Novartis Pharmaceuticals2012-06-01
A Phase 1, Open-label, Multiple Dose Escalation Trial to Determine Safety and Tolerability of Once Daily OPB-111077 in Subjects With Advanced Cancer (NCT01711034)Otsuka Pharmaceutical Development & Commercialization, Inc.2012-06-01
Tripterygium Wilfordii Hook F (TwHF) Treatment for Immune Non-responders With HIV-1 Infection (NCT01666990)Beijing 302 Hospital2012-06-01
Clinic Trial in Phase 1 Using Amniotic Membrane for the Skin Replacement in Big Wounds (NCT01948934)Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia2012-06-01
Single Ascending Dose Study of PRT064445, a Factor Xa (fXa) Inhibitor Antidote (NCT03218241)Portola Pharmaceuticals2012-06-01
A Safety Study of Tocilizumab to Improve Transplant Rates in Highly Sensitized Patients Awaiting Kidney Transplantation (NCT01594424)Cedars-Sinai Medical Center2012-06-01
Drug-interaction Trial in Healthy Subjects With Oral Administration of Empagliflozin (BI 10773), Rifampicin and Probenecid (NCT01634100)Boehringer Ingelheim2012-06-01
A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118 (NCT01670513)Dow Pharmaceutical Sciences2012-06-01
Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer (NCT01625234)Xcovery Holdings, Inc.2012-06-01
Clinical Study to Evaluate Tolerability and Safety of ARK-E021 Foam and to Monitor Clinical Effect in Acne Vulgaris Patients (NCT01494285)M. Arkin 1999 Ltd.2012-06-01
Study in Healthy Volunteers of the Bioavailability of Dexpramipexole Tablets and Food Effects (NCT01607034)Knopp Biosciences2012-06-01
Controlled Trial of Chinese Herbal Medicine to Treat Allergic Rhinitis (NCT02027194)The Hong Kong Polytechnic University2012-06-01
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis (NCT01605708)Regeneron Pharmaceuticals2012-06-01
Pomegranate Extract Supplementation in Colorectal Cancer Patients (NCT01916239)National Research Council, Spain2012-06-01
A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors (NCT01608867)OncoMed Pharmaceuticals, Inc.2012-06-01
A Phase 1, Open-label Study to Investigate the Pharmacokinetics of Tralokinumab (CAT-354) in Adolescents With Asthma (NCT01592396)MedImmune LLC2012-06-01
Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine (NCT01617239)Crucell Holland BV2012-06-01
A Phase I/II Study of the Safety and Efficacy of Sernova's Cell PouchTM for Therapeutic Islet Transplantation (NCT01652911)University of Alberta2012-06-01
A Study of LY2140023 in Healthy Participants (NCT01609218)Denovo Biopharma LLC2012-06-01
Pharmacodynamic Drug Interaction Between Cilostazol and Statins (NCT01870466)Samsung Medical Center2012-06-01
Drug Interaction Study of Isavuconazole and Warfarin in Healthy Male Subjects (NCT01657825)Astellas Pharma Global Development, Inc.2012-06-01
A Study of LY3015014 in Otherwise Healthy Participants With High Low-density Lipoprotein (LDL) Cholesterol (NCT01618916)Eli Lilly and Company2012-06-01
A Phase I Study of LFA102 in Japanese Patients (NCT01610050)Novartis Pharmaceuticals2012-06-01
Pilot Study of a Fluocinolone Acetonide Intravitreal Insert (FA-i) to Treat Intermediate-, Posterior-, or Panuveitis (NCT01781936)Glenn Jaffe2012-06-01
A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previously-Treated AL Amyloidosis (NCT01570387)Boston Medical Center2012-06-01
Valproate as First Line Therapy in Combination With Rituximab and CHOP in Diffuse Large B-cell Lymphoma (NCT01622439)Lund University Hospital2012-06-01
Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy (NCT01192087)Heidelberg University2012-06-01
A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors (NCT01610479)Taiho Pharmaceutical Co., Ltd.2012-06-01
Evaluation of CLP With and Without Spironolactone in Heart Failure Patients With Chronic Kidney Disease (NCT01598740)Sorbent Therapeutics2012-06-01
Melatonin in Healthy Volunteers (NCT01724424)University of Aberdeen2012-06-01
Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLL (NCT01703364)Arbeitsgemeinschaft medikamentoese Tumortherapie2012-06-01
Study of Safety and Preliminary Efficacy for LDK378 in Japanese Patients With Genetic Alterations in Anaplastic Lymphoma Kinase (ALK) (NCT01634763)Novartis Pharmaceuticals2012-06-01
Caspase Inhibition in Islet Transplantation (NCT01653899)University of Alberta2012-06-01
Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal) (NCT01575925)Celgene2012-06-01
A Single and Multiple Dose Study to Assess Blood and Urine Drug Levels of Fostamatinib in Healthy Japanese Subjects (NCT01608542)AstraZeneca2012-06-01
A Study To Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP2408 After Multiple Dose Subcutaneous Injections in Patients With Rheumatoid Arthritis on Methotrexate (NCT02052375)Astellas Pharma Global Development, Inc.2012-06-01
A Study of the Safety and Pharmacokinetics of SAR245409 Tablets in Patients With Solid Tumors or Lymphoma (NCT01596270)Sanofi2012-06-01
Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C (NCT01577758)Millennium Pharmaceuticals, Inc.2012-06-01
Albuterol in Individuals With Late Onset Pompe Disease (LOPD) (NCT01859624)Duke University2012-06-01
A Study to Assess the Pharmacokinetics and Pharmacodynamics of Canagliflozin in Healthy Chinese Volunteers (NCT01707316)Janssen Research & Development, LLC2012-06-01
Lurasidone Pediatric Pharmacokinetics Study (NCT01620060)Sumitomo Pharma America, Inc.2012-06-01
A Single Dose Study of LY3023703 in Healthy Participants (NCT01632579)Eli Lilly and Company2012-06-01
Immunization of Human Volunteers With P. Vivax Irradiated Sporozoites (NCT01082341)Malaria Vaccine and Drug Development Center2012-06-01
A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects (NCT01626976)Pfizer2012-06-01
Cathepsin Activatable Fluorescent Probe (NCT01626066)David Kirsch2012-06-01
A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine ChAdOx1-NP+M1 (NCT01623518)University of Oxford2012-06-01
Therapeutic Riding and Neuromuscular Disease (NCT01621984)University of Ioannina2012-06-01
Efficacy of Whole Extract of Licorice in Neurological Improvement of Patients After Acute Ischemic Stroke (NCT02473458)Shiraz University of Medical Sciences2012-06-01
PillCam® Platform With the PillCam Crohn's Disease Capsule (NCT01631435)Medtronic - MITG2012-06-01
A Trial Investigating the Absolute Bioavailability of Insulin Degludec in Healthy Subjects (NCT01623375)Novo Nordisk A/S2012-06-01
Erythropoietin Therapy for Children With Cerebral Palsy: Phase 1 (NCT01586052)MinYoung Kim, M.D.2012-06-01
A Study to Assess Safety and Pharmacokinetics of Telaprevir in Patients With Hepatic Impairment (NCT01600976)Janssen Infectious Diseases BVBA2012-06-01
Naive T-Cell Depleted DLI Following Allo Stem Cell Transplant (NCT01627275)Mitchell Horwitz, MD2012-06-01
Safety and Efficacy of Intramuscular Electrotransfer of Plasmid AMEP in Patients Suffering From Advanced or Metastatic Melanoma (NCT01764009)Valerio Therapeutics2012-06-01
A Safety and Efficacy Study of a Dexamethasone Drug Delivery System for Postoperative Inflammation and Pain After Cataract Surgery (NCT01605942)Allergan2012-06-01
Phase 1 Safety Study of Single and Multi-Dose Topically Applied OLT1177 Gel in Healthy Subjects (NCT01636141)Olatec Therapeutics, Inc.2012-06-01
Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma (NCT01511302)Revalesio Corporation2012-06-01
Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers (NCT01560325)Chong Kun Dang Pharmaceutical2012-06-01
Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer (NCT01219907)University of Washington2012-06-01
Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Forte (NCT01627158)Orion Corporation, Orion Pharma2012-06-01
Understanding "Heparin Resistance" in Cardiac Surgery (NCT01598883)Massachusetts General Hospital2012-06-01
Study of the Pharmacokinetics of Isavuconazole in Healthy Non-Elderly and Elderly Male and Female Subjects (NCT01657890)Astellas Pharma Global Development, Inc.2012-06-01
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of MT-1303 in Subjects With Inflammatory Bowel Disease (NCT01666327)Tanabe Pharma Corporation2012-06-01
First in Human Trial of TAS266 in Patients With Advanced Solid Tumors (NCT01529307)Novartis Pharmaceuticals2012-06-01
Pilot Study: Active Video Gaming to Facilitate Physical Activity and Quality of Life in Kidney Transplant Recipients (NCT01583257)Nova Scotia Health Authority2012-06-01
Study to Estimate the Pharmacokinetics, Bioavailability and Effect of Food on Single Dose Modified-release Lersivirine 500 mg in Healthy Subjects (NCT01603485)Pfizer2012-06-01
Drug Interaction Study of SAR302503 in Patients With Solid Tumor (NCT01585623)Bristol-Myers Squibb2012-06-01
A Pharmacokinetic Study to Evaluate the Effect of Antacids on Raltegravir (MK-0518) in HIV-Infected Participants (MK-0518-247) (NCT01622673)Merck Sharp & Dohme LLC2012-06-01
A Phase 1 Open-Label Study to Evaluate the Metabolism and Excretion of CC-223 and the Effect of Food on the Pharmacokinetics of CC-223 in Healthy Male Adult Subjects (NCT01611467)Celgene2012-06-01
VG101 Phase I/II to Treat Vulvar and Vaginal Atrophy in Post-Menopausal Women (NCT00453089)Bionovo2012-06-01
A Study of the Effect of Carbamazepine on the Pharmacokinetics of RO4917523 in Healthy Volunteers (NCT01629368)Hoffmann-La Roche2012-06-01
Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers (NCT01610310)Biogen2012-06-01
Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder (NCT01371110)Wayne Goodman MD2012-06-01
Crossover Trial of the Effect of a High-Fat Meal on the PK of Oral CHR 2797 in Healthy Male Subjects (NCT01638442)CTI BioPharma2012-06-01
Internet Intervention for the Prevention of Depression - Approaches to Improving Mood (NCT01080105)Northwestern University2012-06-01
Mobile Phone Text Message Program to Understand Symptoms and Improve Outcomes in Minor Head Injury Patients (NCT01668342)University of Pittsburgh2012-06-01
Safety & Efficacy Study of Gemcitabine...With High Dose IV Vit. C (HDIVC) (NCT01654861)Eastern Regional Medical Center2012-06-01
A Study to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mg (NCT01654601)Dong Wha Pharmaceutical Co. Ltd.2012-06-01
AZD8683 Multiple Dose Study in Healthy Volunteers and Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01584739)AstraZeneca2012-06-01
Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway (NCT01601184)Centre Leon Berard2012-06-01
Rapid Acclimatization to Hypoxia at Altitude (NCT01702025)Colorado State University2012-06-01
A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal Cancer (NCT01589419)AbbVie (prior sponsor, Abbott)2012-06-01
Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5% (NCT01607671)Fraser Health2012-06-01
Potential Use of Indocyanine Green as a Fluorescent Agent for Definition of Surgical Margins in Cancer (NCT01884584)Emory University2012-06-01
Psychological First Aid for Victims of Crime (NCT01934348)Medical University of South Carolina2012-06-01
A Pharmacokinetic Interaction Study Between TMC435, Atorvastatin and Simvastatin in Healthy Participants (NCT01689623)Janssen Research & Development, LLC2012-06-01
Open Study Assessing the Feasibility of Minocycline in Patients With Unipolar Depression (NCT01574742)Shalvata Mental Health Center2012-06-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.